Serum Amyloid a promotes ABCA1-dependent and ABCA1-independent lipid efflux from cells

Biochemical and Biophysical Research Communications

Volumn 321, Issue 4, 2004, Pages 936-941

  Stonik, John A ^a   Remaley, Alan T ^a   Demosky, Steve J ^a   Neufeld, Edward B ^a   Bocharov, Alexander ^b   Brewer, H Bryan ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

ABCA1 transporter; Apolipoprotein A I; Atherosclerosis; Cholesterol; Serum amyloid A

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; CHOLESTEROL; DETERGENT; LIPID; PARAFORMALDEHYDE; PHOSPHOLIPID; PROTEIN; SERUM AMYLOID A; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; EXPERIMENTAL TEST; EXTRACTION; FIBROBLAST; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; LIPID PEROXIDATION; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; TANGIER DISEASE;

APOLIPOPROTEINS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CHOLESTEROL; HELA CELLS; HUMANS; LIPID METABOLISM; PHOSPHOLIPIDS; RECOMBINANT PROTEINS; SERUM AMYLOID A PROTEIN; TANGIER DISEASE; TRANSFECTION;

EID: 3843107923     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.07.052     Document Type: Article

References (32)

1. E. Malle, A. Steinmetz, and J.G. Raynes Serum amyloid A (SAA): an acute phase protein and apolipoprotein Atherosclerosis 102 1993 131 146
2. C.M. Uhlar, and A.S. Whitehead Serum amyloid A, the major vertebrate acute-phase reactant Eur. J. Biochem. 265 1999 501 523
3. S. Urieli-Shoval, R.P. Linke, and Y. Matzner Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states Curr. Opin. Hematol. 7 2000 64 69
4. A. Salazar, X. Pinto, and J. Mana Serum amyloid A and high-density lipoprotein cholesterol: serum markers of inflammation in sarcoidosis and other systemic disorders Eur. J. Clin. Invest. 31 2001 1070 1077
5. P.M. Clifton, A.M. Mackinnon, and P.J. Barter Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction J. Lipid Res. 26 1985 1389 1398
6. W. Turnell, R. Sarra, I.D. Glover, and J.O. Baum Secondary structure prediction of human SAA1 presumptive identification of calcium and lipid binding sites Mol. Biol. Med. 3 1986 387 407
7. J.P. Segrest, H.J. Pownall, R.L. Jackson, G.G. Glenner, and P.S. Pollock Amyloid A: amphipathic helixes and lipid binding Biochemistry 15 1976 3187 3191
8. J.P. Segrest, D.W. Garber, C.G. Brouillette, S.C. Harvey, and G.M. Anantharamaiah The amphipathic alpha helix: a multifunctional structural motif in plasma apolipoproteins Adv. Protein Chem. 45 1994 303 369
9. R.L. Meek, S. Urieli-Shoval, and E.P. Benditt Expression of apolipoprotein serum amyloid A mRNA in human atherosclerotic lesions and cultured vascular cells: implications for serum amyloid A function Proc. Natl. Acad. Sci. USA 91 1994 3186 3190
10. R. Kisilevsky, and S.P. Tam Acute phase serum amyloid A, cholesterol metabolism, and cardiovascular disease Pediatr. Pathol. Mol. Med. 21 2002 291 305
11. A. Salazar, J. Mana, C. Fiol, I. Hurtado, J.M. Argimon, R. Pujol, and X. Pinto Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis Atherosclerosis 152 2000 497 502
12. H. Hosoai, N.R. Webb, J.M. Glick, U.J. Tietge, M.S. Purdom, F.C. de Beer, and D.J. Rader Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-Itransgenic mice J. Lipid Res. 40 1999 648 653
13. C.L. Banka, T. Yuan, M.C. de Beer, M. Kindy, L.K. Curtiss, and F.C. de Beer Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux J. Lipid Res. 36 1995 1058 1065
14. A. Artl, G. Marsche, S. Lestavel, W. Sattler, and E. Malle Role of serum amyloid A during metabolism of acute-phase HDL by macrophages Arterioscler. Thromb. Vasc. Biol. 20 2000 763 772
15. T. Yamada, T. Miida, T. Yamaguchi, and Y. Itoh Effect of serum amyloid A on cellular affinity of low density lipoprotein Eur. J. Clin. Chem. Clin. Biochem. 35 1997 421 426
16. R. Kisilevsky, and L. Subrahmanyan Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function Lab. Invest. 66 1992 778 785
17. J.S. Liang, B.M. Schreiber, M. Salmona, G. Phillip, W.A. Gonnerman, F.C. de Beer, and J.D. Sipe Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aorticsmooth muscle and HepG2 cells J. Lipid Res. 37 1996 2109 2116
18. J.S. Liang, and J.D. Sipe Recombinant human serum amyloid A (apoSAAp) binds cholesterol and modulates cholesterol flux J. Lipid Res. 36 1995 37 46
19. S.P. Tam, A. Flexman, J. Hulme, and R. Kisilevsky Promoting export of macrophage cholesterol: the physiological role of a major acute-phase protein, serum amyloid A 2.1 J. Lipid Res. 43 2002 1410 1420
20. R. Kisilevsky, and S.P. Tam Macrophage cholesterol efflux and the active domains of serum amyloid A 2.1 J. Lipid Res. 44 2003 2257 2269
21. A.R. Tall, P. Costet, and N. Wang Regulation and mechanisms of macrophage cholesterol efflux J. Clin. Invest. 110 2002 899 904
22. C.J. Fielding, and P.E. Fielding Cellular cholesterol efflux Biochim. Biophys. Acta 1533 2001 175 189
23. J.F. Oram The cholesterol mobilizing transporter ABCA1 as a new therapeutic target for cardiovascular disease Trends Cardiovasc. Med. 12 2002 170 175
24. A.T. Remaley, S. Rust, M. Rosier, C. Knapper, L. Naudin, C. Broccardo, K.M. Peterson, C. Koch, I. Arnould, C. Prades, N. Duverger, H. Funke, G. Assmann, M. Dinger, M. Dean, G. Chimini, S. Santamarina-Fojo, D.S. Fredrickson, P. Denefle, and H.B. Brewer Jr. Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred Proc. Natl. Acad. Sci. USA 96 1999 12685 12690
25. A.T. Remaley, J.A. Stonik, S.J. Demosky, E.B. Neufeld, A.V. Bocharov, T.G. Vishnyakova, T.L. Eggerman, A.P. Patterson, N.J. Duverger, S. Santamarina-Fojo, and H.B. Brewer Jr. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter Biochem. Biophys. Res. Commun. 280 2001 818 823
26. A.T. Remaley, F. Thomas, J.A. Stonik, S.J. Demosky, S.E. Bark, E.B. Neufeld, A.V. Bocharov, T.G. Vishnyakova, A.P. Patterson, T.L. Eggerman, S. Santamarina-Fojo, and H.B. Brewer Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway J. Lipid Res. 44 2003 828 836
27. N. Eriksen, and E.P. Benditt Serum amyloid A (ApoSAA) and lipoproteins Methods Enzymol. 128 1986 311 320
28. H.B. Brewer Jr., R. Ronan, M. Meng, and C. Bishop Isolation and characterization of apolipoproteins A-I, A-II, and A-IV Methods Enzymol. 128 1986 223 246
29. A. Jonas Reconstitution of high-density lipoproteins Methods Enzymol. 128 1986 553 582
30. A.T. Remaley, U.K. Schumacher, J.A. Stonik, B.D. Farsi, H. Nazih, and H.B. Brewer Jr. Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux Arterioscler. Thromb. Vasc. Biol. 17 1997 1813 1821
31. Y. Takahashi, M. Miyata, P. Zheng, T. Imazato, A. Horwitz, and J.D. Smith Identification of cAMP analogue inducible genes in RAW264 macrophages Biochim. Biophys. Acta 1492 2000 385 394
32. T. Miida, T. Yamada, T. Yamadera, K. Ozaki, K. Inano, and M. Okada Serum amyloid A protein generates pre beta 1 high-density lipoprotein from alpha-migrating high-density lipoprotein Biochemistry 38 1999 16958 16962